diabetes mellitus
Conditions
Interventions
Intervention group:In the intervention group, healthcare professionals participating in the trial will engage in monthly case discussion conferences within the PHIs.
The case discussion conferences wi
Sponsors
China Center for Health Development Studies, Peking University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The participants in the study consist of primary healthcare institutions (PHIs), family doctor teams of PHIs, specialists, and patients with T2DM. PHIs and family doctor teams In the study, six PHIs at each of the two trial centers, which are responsible for managing T2DM patients within the community, will be selected. A typical team composition comprises a minimum of three individuals with distinct roles, such as a doctor, a nurse, and a public health worker. Regarding the inclusion criteria, in each PHI (cluster), family doctor contract services must be carried out in the form of team services within the community. Furthermore, these institutions should not be concurrently involved in any other clinical trial, and they should possess an information system facilitating access to patients' health records. All family doctor teams within the selected institutions will participate in this study. Eligible family doctor teams will be included in this study under the agreement of all team members. Specialists of secondary or tertiary hospitals The specialists assigned to PHIs will be chosen from a pool of endocrinologists or diabetes specialists working in secondary or tertiary hospitals. Inclusion criteria for these specialist physicians, contingent upon their willingness to participate in this study, are as follows: (1) specialization closely related to diabetes mellitus, with their working department being either Endocrinology or a specialized Diabetes Department; (2) accumulated work experience of five years or longer; (3) stable employment status within their current position for the upcoming year, without any plans for job changes. To assess potential sources of variance stemming from individual specialists, we will conduct a baseline evaluation encompassing their demographic details, medical capabilities, and specialty expertise. Patients All patients diagnosed with T2DM who received care directly from the participating family doctor teams will be eligible to participate in this trial, regardless of age.
Exclusion criteria
Exclusion criteria: Patients will be excluded if they: (1) have a terminal illness with a life expectancy of fewer than 12 months; (2) are suffering from dementia or other diseases that impair their ability to communicate; (3) are concurrently enrolled in other intervention projects that may influence their health conditions regarding diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fasting blood glucose (FBG) ;HbA1c; | — |
Secondary
| Measure | Time frame |
|---|---|
| systolic blood pressure;diastolic blood pressure;quality of life;frequency of outpatients within a month;frequency of inpatients within a year;patient satisfaction; | — |
Countries
China
Contacts
Public ContactYuan Beibei
China Center for Health Development Studies, Peking University
Outcome results
None listed